David Vlahov

Q: What Schools Are Affiliated With David Vlahov

David Vlahov is affiliated with the following schools: University of California, Berkeley, Yale University, University of Michigan, Medical University of South Carolina, Earlham College, Johns Hopkins University, Columbia University, University of California, San Francisco, Kyoto University, University of Alabama at Birmingham

David Vlahov's AcademicInfluence.com Rankings

David Vlahov

Nursing

#40

World Rank

#54

Historical Rank

nursing Degrees

David Vlahov

Medical

#756

World Rank

#995

Historical Rank

Public Health

#93

World Rank

#99

Historical Rank

Epidemiology

#109

World Rank

#120

Historical Rank

medical Degrees

Download Badge

Nursing
Medical

David Vlahov's Degrees

PhD Epidemiology Johns Hopkins University
Masters Public Health University of California, Berkeley
Bachelors Nursing University of California, San Francisco

Why Is David Vlahov Influential?

(Suggest an Edit or Addition)

According to Wikipedia, David Vlahov is an American epidemiologist and professor emeritus at the UCSF School of Nursing, of which he previously served as dean from April 2011 to August 2016. He is also the editor-in-chief of the Journal of Urban Health, and has been a member of the National Academy of Medicine since 2011. He is known for researching issues related to social determinants of health, such as the effectiveness of needle exchange programs. With Sandro Galea, he has also researched psychological responses to the September 11 attacks among residents of New York City.

(See a Problem?)

David Vlahov's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene (1996) (2691)
Psychological sequelae of the September 11 terrorist attacks in New York City. (2002) (1666)
HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. (1999) (1317)
Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS (2002) (1231)
HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection (2004) (1202)
What predicts psychological resilience after disaster? The role of demographics, resources, and life stress. (2007) (1143)
The natural history of hepatitis C virus infection: host, viral, and environmental factors. (2000) (1137)
The epidemiology of post-traumatic stress disorder after disasters. (2005) (1130)
Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. (1997) (963)
Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. (2001) (917)
Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC) (1998) (761)
Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. (1996) (708)
APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. (2011) (670)
MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis (2008) (667)
Trends of probable post-traumatic stress disorder in New York City after the September 11 terrorist attacks. (2003) (562)
The social epidemiology of substance use. (2004) (528)
Persistence of viremia and the importance of long‐term follow‐up after acute hepatitis C infection (1999) (527)
Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. (2001) (520)
Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation. (1996) (519)
Genetic acceleration of AIDS progression by a promoter variant of CCR5. (1998) (483)
Social determinants and the health of drug users: socioeconomic status, homelessness, and incarceration. (2002) (477)
Protection against persistence of hepatitis C (2002) (471)
The Alive Study: A Longitudinal Study of HIV-1 Infection in Intravenous Drug Users: Description of Methods (1991) (463)
A high-density admixture map for disease gene discovery in african americans. (2004) (450)
Urbanization, urbanicity, and health (2002) (445)
Psychological Resilience After Disaster (2006) (432)
Increased use of cigarettes, alcohol, and marijuana among Manhattan, New York, residents after the September 11th terrorist attacks. (2002) (430)
Urban health: evidence, challenges, and directions. (2005) (416)
Urban as a Determinant of Health (2007) (410)
Mental, Physical, and Behavioral Outcomes Associated With Perceived Work Stress in Police Officers (2009) (379)
HIV infection is associated with an increased risk for lung cancer, independent of smoking. (2007) (378)
Slum Health: Arresting COVID-19 and Improving Well-Being in Urban Informal Settlements (2020) (376)
Sex differences in HIV-1 viral load and progression to AIDS (1998) (370)
Correlates of Hepatitis C Virus Infections among Injection Drug Users (1995) (364)
Urban built environment and depression: a multilevel analysis (2005) (363)
Initial plasma HIV-1 RNA levels and progression to AIDS in women and men. (2001) (352)
Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. (1998) (350)
Opiates, cocaine and alcohol combinations in accidental drug overdose deaths in New York City, 1990-98. (2003) (338)
Limited Uptake of Hepatitis C Treatment Among Injection Drug Users (2008) (336)
Sex differences in risk factors for hiv seroconversion among injection drug users: a 10-year perspective. (2001) (334)
Cities and population health (2004) (330)
Television Images and Psychological Symptoms after the September 11 Terrorist Attacks (2002) (323)
Challenges and Facilitating Factors in Sustaining Community-Based Participatory Research Partnerships: Lessons Learned from the Detroit, New York City and Seattle Urban Research Centers (2006) (314)
Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10. (2000) (314)
A PROSPECTIVE STUDY OF ADHERENCE AND VIRAL LOAD IN A LARGE MULTI-CENTER COHORT OF HIV-INFECTED WOMEN (2002) (303)
Effects of CCR5- 32, CCR2-64I, and SDF-1 3A Alleles on HIV-1 Disease Progression: An International Meta-Analysis of Individual-Patient Data (2001) (282)
Urban neighborhood poverty and the incidence of depression in a population-based cohort study. (2007) (282)
Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons. (2004) (271)
Self-reported antiretroviral therapy in injection drug users. (1998) (268)
Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users. (1996) (247)
Seroreactivity to hepatitis E virus in areas where the disease is not endemic (1997) (242)
Prospective evaluation of community-acquired acute-phase hepatitis C virus infection. (2005) (238)
Prognostic indicators for AIDS and infectious disease death in HIV-infected injection drug users: plasma viral load and CD4+ cell count. (1998) (237)
Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland (1997) (234)
AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis (2005) (230)
Increased mortality associated with vitamin A deficiency during human immunodeficiency virus type 1 infection. (1993) (223)
Compliance with universal precautions among health care workers at three regional hospitals. (1996) (222)
The role of needle exchange programs in HIV prevention. (1998) (218)
Socially desirable responding and self-reported HIV infection risk behaviors among intravenous drug users. (1993) (214)
APOBEC3G Genetic Variants and Their Influence on the Progression to AIDS (2004) (208)
Prevalence of tuberculin positivity and skin test anergy in HIV-1-seropositive and -seronegative intravenous drug users. (1992) (204)
Using social network analysis to study patterns of drug use among urban drug users at high risk for HIV/AIDS. (1995) (204)
Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 positive women (2008) (204)
Modulating influence on HIV/AIDS by interacting RANTES gene variants (2002) (202)
HLA-Cw*04 and Hepatitis C Virus Persistence (2002) (200)
Racial differences in HLA class II associations with hepatitis C virus outcomes. (2001) (200)
Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users (2001) (200)
Risk behaviors by audio computer-assisted self-interviews among HIV-seropositive and HIV-seronegative injection drug users. (2002) (193)
Posttraumatic stress disorder in Manhattan, New York City, after the September 11th terrorist attacks (2002) (191)
Correlates of HIV infection among young adult short-term injection drug users (2000) (191)
Factors associated with prevalent hepatitis C: differences among young adult injection drug users in lower and upper Manhattan, New York City. (2001) (188)
Longitudinal patterns of drug injection behavior in the ALIVE Study cohort,1988-2000: description and determinants. (2003) (182)
Association of drug injection patterns with antibody to human immunodeficiency virus type 1 among intravenous drug users in Baltimore, Maryland. (1990) (180)
Sex differences in longitudinal human immunodeficiency virus type 1 RNA levels among seroconverters. (1999) (177)
Explaining racial disparities in incidence of and survival from out-of-hospital cardiac arrest. (2007) (176)
Neighborhood income and income distribution and the use of cigarettes, alcohol, and marijuana. (2007) (175)
Neighborhood characteristics and disability in older adults. (2009) (175)
Prevalence of hepatitis C virus infection among injection drug users in the United States, 1994-2004. (2008) (175)
Wide variation in risk of wound infection following clean neurosurgery. Implications for perioperative antibiotic prophylaxis. (1985) (171)
Injecting misuse of buprenorphine among French drug users. (2001) (168)
The urban built environment and overdose mortality in New York City neighborhoods. (2005) (168)
Design and baseline participant characteristics of the Human Immunodeficiency Virus Epidemiology Research (HER) Study: a prospective cohort study of human immunodeficiency virus infection in US women. (1997) (167)
Longitudinal predictors of injection cessation and subsequent relapse among a cohort of injection drug users in Baltimore, MD, 1988-2000. (2006) (166)
Molecular and geographic patterns of tuberculosis transmission after 15 years of directly observed therapy. (1998) (165)
Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China. (2004) (165)
Opiates as potential cofactors in progression of HIV-1 infections to AIDS (1998) (164)
Screening for Hepatitis C Virus in Human Immunodeficiency Virus-Infected Individuals (2000) (161)
Television Images and Probable Posttraumatic Stress Disorder After September 11: The Role of Background Characteristics, Event Exposures, and Perievent Panic (2004) (161)
Drug use, misuse, and the urban environment. (2005) (160)
Sustained increased consumption of cigarettes, alcohol, and marijuana among Manhattan residents after september 11, 2001. (2004) (159)
Multilevel community-based intervention to increase access to sterile syringes among injection drug users through pharmacy sales in New York City. (2007) (159)
High-risk behaviors associated with transition from illicit non-injection to injection drug use among adolescent and young adult drug users: a case-control study. (2002) (158)
Determinants of counseling for children in Manhattan after the September 11 attacks. (2002) (158)
Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City. (2003) (158)
Compliance with universal precautions among health care workers at three regional hospitals (1995) (157)
Contextual determinants of drug use risk behavior: A theoretic framework (2003) (155)
Identifying injection drug users at risk of nonfatal overdose. (2007) (153)
Childhood sexual abuse and age at initiation of injection drug use. (2005) (153)
People and places: behavioral settings and personal network characteristics as correlates of needle sharing. (1996) (153)
The trading of sex for drugs or money and HIV seropositivity among female intravenous drug users. (1994) (152)
Blood-borne and sexual transmission of human herpesvirus 8 in women with or at risk for human immunodeficiency virus infection. (2001) (151)
Cervical neoplasia and repeated positivity of human papillomavirus infection in human immunodeficiency virus-seropositive and -seronegative women. (2000) (150)
Mycarditis and cardiotropic viral infection associated with severe left ventricular dysfunction in late-stage infection with human immunodeficiency virus (1994) (150)
Vitamin A deficiency and wasting as predictors of mortality in human immunodeficiency virus-infected injection drug users. (1995) (147)
Evaluation of an Intervention to Increase Screening Colonoscopy in an Urban Public Hospital Setting (2006) (146)
Obesity and diabetes as risk factors for postoperative wound infections after cardiac surgery. (1988) (145)
Mental health service and medication use in New York City after the September 11, 2001, terrorist attack. (2004) (145)
Buprenorphine use: the international experience. (2006) (144)
PTSD and depression after the Madrid March 11 train bombings. (2006) (142)
Epidemiology of falls among patients in a rehabilitation hospital. (1990) (140)
Prospective study of infective endocarditis among injection drug users. (2002) (140)
Reductions in high-risk drug use behaviors among participants in the Baltimore needle exchange program. (1997) (140)
Effects of race, neighborhood, and social network on age at initiation of injection drug use. (2005) (139)
Consumption of Cigarettes, Alcohol, and Marijuana Among New York City Residents Six Months After the September 11 Terrorist Attacks (2004) (139)
Hispanic ethnicity and post-traumatic stress disorder after a disaster: evidence from a general population survey after September 11, 2001. (2004) (137)
Cost and cost-effectiveness of increasing access to sterile syringes and needles as an HIV prevention intervention in the United States. (1998) (134)
Prevalence and cumulative incidence of and risk factors for anemia in a multicenter cohort study of human immunodeficiency virus-infected and -uninfected women. (2002) (133)
Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data. (2001) (133)
Changes in blood-borne infection risk among injection drug users. (2011) (131)
Drug smoking, Pneumocystis carinii pneumonia, and immunosuppression increase risk of bacterial pneumonia in human immunodeficiency virus-seropositive injection drug users. (1994) (131)
Prevalence and incidence of left ventricular dysfunction in patients with human immunodeficiency virus infection. (1993) (131)
Neighborhood characteristics and change in depressive symptoms among older residents of New York City. (2009) (131)
End-stage renal disease and chronic kidney disease in a cohort of African-American HIV-infected and at-risk HIV-seronegative participants followed between 1988 and 2004 (2007) (130)
Circumstances of witnessed drug overdose in New York City: implications for intervention. (2005) (129)
New evidence on intravenous cocaine use and the risk of infection with human immunodeficiency virus type 1. (1991) (129)
Temporal trends in the incidence of human immunodeficiency virus infection and risk behavior among injection drug users in Baltimore, Maryland, 1988-1998. (2002) (127)
Prevalence of antibody to HIV-1 among entrants to US correctional facilities. (1991) (127)
The role of substance abuse in HIV disease progression: reconciling differences from laboratory and epidemiologic investigations. (2005) (127)
Antibody to hepatitis C virus among cardiac surgery patients, homosexual men, and intravenous drug users in Baltimore, Maryland. (1991) (126)
Utilization of health services in a cohort of intravenous drug users with known HIV-1 serostatus. (1991) (126)
Neighborhoods and HIV: a social ecological approach to prevention and care. (2013) (125)
The built environment and alcohol consumption in urban neighborhoods. (2007) (125)
Patterns of HIV-1 evolution in individuals with differing rates of CD4 T cell decline. (1998) (124)
Bacterial infections and skin cleaning prior to injection among intravenous drug users. (1992) (124)
Income distribution and risk of fatal drug overdose in New York City neighborhoods. (2003) (124)
Seroepidemiology of hepatitis B virus in a population of injecting drug users. Association with drug injection patterns. (1995) (123)
Defining neighborhood boundaries for urban health research. (2007) (122)
Prevalence of lower genital tract infections among human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women. HIV Epidemiology Research Study Group. (1999) (122)
Access to medical care and service utilization among injection drug users with HIV/AIDS. (2001) (122)
Category of exposure to HIV and age in the progression to AIDS: longitudinal study of 1199 people with known dates of seroconversion (1996) (120)
Association of DC-SIGN Promoter Polymorphism with Increased Risk for Parenteral, but Not Mucosal, Acquisition of Human Immunodeficiency Virus Type 1 Infection (2004) (120)
Factors Associated with Adolescent Initiation of Injection Drug Use (2001) (120)
Social Determinants of the Health of Urban Populations: Methodologic Considerations (2007) (118)
Social Circumstances of Initiation of Injection Drug Use and Early Shooting Gallery Attendance: Implications for HIV Intervention Among Adolescent and Young Adult Injection Drug Users (2003) (117)
Transmission of HIV-1 within a statewide prison system. (1988) (116)
Determinants of the quantity of hepatitis C virus RNA. (2000) (116)
Temporal association between implementation of universal precautions and a sustained, progressive decrease in percutaneous exposures to blood. (1994) (116)
Class II HLA alleles and hepatitis B virus persistence in African Americans. (1999) (116)
Cytotoxic T-Lymphocyte Antigen 4 Gene and Recovery from Hepatitis B Virus Infection (2004) (114)
HIV Pre-exposure Prophylaxis (PrEP) Uptake and Retention Among Men Who Have Sex with Men in a Community-Based Sexual Health Clinic (2018) (114)
Risk factors for shooting gallery use and cessation among intravenous drug users. (1991) (114)
Non-fatal overdose and subsequent drug treatment among injection drug users. (2006) (113)
Gender, Social Support, and Posttraumatic Stress in Postwar Kosovo (2004) (113)
Utilization of mental health services following the September 11th terrorist attacks in Manhattan, New York City. (2002) (111)
Clinicians' Views of Hepatitis C Virus Treatment Candidacy With Direct-Acting Antiviral Regimens for People Who Inject Drugs (2016) (110)
Eviction, Health Inequity, and the Spread of COVID-19: Housing Policy as a Primary Pandemic Mitigation Strategy (2020) (110)
My place, your place, and no place: Behavior settings as a risk factor for HIV-related injection practices of drug users in Baltimore, Maryland (1994) (110)
Selective risk taking among needle exchange participants: implications for supplemental interventions. (2001) (110)
Stigmatization of newly emerging infectious diseases: AIDS and SARS. (2006) (110)
Socially desirable response tendency as a correlate of accuracy of self-reported HIV serostatus for HIV seropositive injection drug users. (1998) (110)
High prevalence of occult hepatitis B in Baltimore injection drug users (2004) (109)
Drug abuse treatment success among needle exchange participants. (1998) (107)
The long-term outcome of a personal network-oriented HIV prevention intervention for injection drug users: The SAFE study (1996) (106)
CANADIAN ILLICIT OPIATE USERS’ VIEWS ON METHADONE AND OTHER OPIATE PRESCRIPTION TREATMENT: AN EXPLORATORY QUALITATIVE STUDY (2002) (106)
Association of antibody to GB virus C (hepatitis G virus) with viral clearance and protection from reinfection. (1998) (106)
Needle-exchange attendance and health care utilization promote entry into detoxification (1999) (105)
Hepatitis A among homosexual men and injection drug users: more evidence for vaccination. (1997) (105)
Myocarditis and cardiotropic viral infection associated with severe left ventricular dysfunction in late-stage infection with human immunodeficiency virus. (1994) (103)
Antibody responses to Haemophilus influenzae type B vaccines in men with human immunodeficiency virus infection. (1991) (103)
Antibodies to Bartonella species in inner-city intravenous drug users in Baltimore, Md. (1996) (102)
Effects of CCR5-Δ32 and CCR2-64I alleles on HIV-1 disease progression: the protection varies with duration of infection (2003) (102)
Access to antiretroviral treatment among French HIV infected injection drug users: the influence of continued drug use. MANIF 2000 Study Group. (1999) (102)
Personal network characteristics as antecedents to needle-sharing and shooting gallery attendance (1995) (102)
Prevention of HIV infection among injection drug users in resource-limited settings. (2010) (102)
Compliance with universal precautions in correctional health care facilities. (1999) (102)
Updating the infection risk reduction hierarchy: Preventing transition into injection (2004) (102)
Revisiting the role of the urban environment in substance use: the case of analgesic overdose fatalities. (2013) (101)
Can HIV epidemics among injection drug users be prevented? (1998) (101)
Longitudinal Determinants of Posttraumatic Stress in a Population-Based Cohort Study (2008) (101)
Temporal trends of incident human immunodeficiency virus infection in a cohort of injecting drug users in Baltimore, Md. (1995) (100)
Beyond Urban Penalty and Urban Sprawl: Back to Living Conditions as the Focus of Urban Health (2005) (99)
Prescription opioid mortality trends in New York City, 1990-2006: examining the emergence of an epidemic. (2013) (99)
Detection of HIV-1 DNA in needle/syringes, paraphernalia, and washes from shooting galleries in Miami: a preliminary laboratory report. (1996) (98)
A prospective, community‐based evaluation of liver enzymes in individuals with hepatitis C after drug use (1999) (98)
Mortality in HIV-seropositive versus -seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy. (2004) (97)
Policing, drugs, and the homicide decline in New York City in the 1990s (2007) (96)
Gender differences in the initiation of injection drug use among young adults (2000) (95)
Mitochondrial DNA haplogroups influence AIDS progression (2008) (93)
Self-Report Interview Data for a Study of HIV-1 Infection among Intravenous Drug Users: Description of Methods and Preliminary Evidence on Validity (1991) (93)
Correlates of enrollment in methadone maintenance treatment programs differ by HIV-serostatus (2000) (92)
Needle exchange programs for the prevention of human immunodeficiency virus infection: epidemiology and policy. (2001) (92)
Comparison of a tuberculin interferon-gamma assay with the tuberculin skin test in high-risk adults: effect of human immunodeficiency virus infection. (1997) (92)
Cancer incidence in women with or at risk for HIV (2001) (91)
Violence Among Women with or at Risk for HIV Infection (1998) (91)
Psychological resources protect health: 5-year survival and immune function among HIV-infected women from four US cities (2006) (90)
Coronary artery calcification, atherogenic lipid changes, and increased erythrocyte volume in black injection drug users infected with human immunodeficiency virus-1 treated with protease inhibitors. (2002) (90)
Reduced risk of AIDS lymphoma in individuals heterozygous for the CCR5-delta32 mutation. (1999) (90)
Correlates of needle sharing among injection drug users. (1994) (89)
The relationship between risk networks' patterns of crack cocaine and alcohol consumption and HIV-related sexual behaviors among adult injection drug users: a prospective study. (1996) (89)
Neighborhood-Level Correlates of Consistent Condom Use among Men Who have Sex with Men: A Multi-Level Analysis (2010) (88)
Policing and risk of overdose mortality in urban neighborhoods. (2011) (88)
Job Loss, Unemployment, Work Stress, Job Satisfaction, and the Persistence of Posttraumatic Stress Disorder One Year After the September 11 Attacks (2004) (87)
Addressing the Social and Environmental Determinants of Urban Health Equity: Evidence for Action and a Research Agenda (2011) (86)
Relationship of Self-Reported Asthma Severity and Urgent Health Care Utilization to Psychological Sequelae of the September 11, 2001 Terrorist Attacks on the World Trade Center Among New York City Area Residents (2003) (84)
Lack of behavior change after disclosure of hepatitis C virus infection among young injection drug users in Baltimore, Maryland. (2002) (84)
The effectiveness of needle exchange programs: A review of the science and policy (2001) (83)
Illicit drug use, depression and their association with highly active antiretroviral therapy in HIV-positive women. (2007) (83)
APOL 1 Genetic Variants in Focal Segmental Glomerulosclerosis and HIV-Associated Nephropathy (2011) (83)
Posttraumatic stress in women after the September 11 terrorist attacks in New York City. (2003) (83)
Influence of CCR5 promoter haplotypes on AIDS progression in African–Americans (2000) (83)
The urban health “advantage” (2005) (82)
Suspected determinants of enrollment into detoxification and methadone maintenance treatment among injecting drug users. (1994) (81)
The effect of a needle exchange program on numbers of discarded needles: a 2-year follow-up. (2000) (81)
Prospective Microbiologic Surveillance in Control of Nosocomial Methicillin-Resistant Staphylococcus aureus (1987) (81)
Severity and correlates of liver disease in hepatitis C virus–infected injection drug users (2002) (81)
Evidence of rodent-associated Bartonella and Rickettsia infections among intravenous drug users from Central and East Harlem, New York City. (2001) (80)
Receptive Syringe Sharing Among Injection Drug Users in Harlem and the Bronx During the New York State Expanded Syringe Access Demonstration Program (2005) (80)
The influence of needle exchange programs on injection risk behaviors and infection with hepatitis C virus among young injection drug users in select cities in the United States, 1994-2004. (2009) (79)
Longitudinal human immunodeficiency virus type 1 load in the italian seroconversion study: correlates and temporal trends of virus load. (1999) (79)
Sex differences in HIV-1 viral load and progression to AIDS (1999) (78)
MYH 9 is a major-effect risk gene for focal segmental glomerulosclerosis (2008) (77)
Measurement of HIV risk behaviors among intravenous drug users. (1992) (77)
Correlates of infection control practices in dentistry. (1998) (76)
Psychiatric Medication Use Among Manhattan Residents Following the World Trade Center Disaster (2003) (76)
A framework for understanding factors that affect access and utilization of treatment for hepatitis C virus infection among HCV-mono-infected and HIV/HCV-co-infected injection drug users. (2005) (76)
Trends of HIV-1 risk reduction among initiates into intravenous drug use 1982-1987. (1991) (75)
Association of sex, hygiene and drug equipment sharing with hepatitis C virus infection among non-injecting drug users in New York City. (2005) (75)
Update on the seroepidemiology of human immunodeficiency virus in the United States household population: NHANES III, 1988-1994. (1997) (74)
Sexual and drug risk-related behaviours after initiating highly active antiretroviral therapy among injection drug users (2001) (74)
Syringe vending machines for injection drug users: an experiment in Marseille, France. (1999) (74)
Satellite exchange in the Baltimore Needle Exchange Program. (1998) (73)
Epidemiology of hepatitis B virus infections among injecting drug users: seroprevalence, risk factors, and viral interactions. (1994) (73)
Television Watching and the Risk of Incident Probable Posttraumatic Stress Disorder: A Prospective Evaluation (2007) (73)
Mortality risk among new onset injection drug users. (2004) (72)
Isoniazid preventive therapy, hepatitis C virus infection, and hepatotoxicity among injection drug users infected with Mycobacterium tuberculosis. (2001) (72)
Prevalence and incidence of hepatitis C virus infection among male prison inmates in Maryland (1993) (72)
Bacterial pneumonia in adult populations with human immunodeficiency virus (HIV) infection. (1993) (72)
Incubation period of human immunodeficiency virus. (1993) (71)
Vitamin A supplementation and human immunodeficiency virus load in injection drug users. (1998) (71)
The Urban Environment and Sexual Risk Behavior among Men who have Sex with Men (2006) (71)
Neighborhood poverty and injection cessation in a sample of injection drug users. (2010) (70)
Impact of HIV infection on non‐AIDS mortality among Italian injecting drug users (1994) (69)
Changes in T-lymphocyte subsets in intravenous drug users with HIV-1 infection. (1992) (69)
Racial/ethnic disparities in overdose mortality trends in New York City, 1990–1998 (2003) (69)
Distribution of influenza vaccine to high-risk groups. (2006) (68)
Sexually transmitted diseases in a population of intravenous drug users: association with seropositivity to the human immunodeficiency virus (HIV). (1991) (68)
Medical eligibility, comprehension of the consent process, and retention of injection drug users recruited for an HIV vaccine trial. (1995) (68)
Review of Accidents/Injuries Among Emergency Medical Services Workers in Baltimore, Maryland (1995) (68)
Correlates of Initiation of Injection Drug Use Among Young Drug Users in Baltimore, Maryland: The Need for Early Intervention (2005) (68)
Misdemeanor Policing, Physical Disorder, and Gun-related Homicide: A Spatial Analytic Test of “Broken-Windows” Theory (2009) (67)
The prevalence of homelessness among injection drug users with and without HIV infection (2000) (66)
Serum albumin as a prognostic indicator for HIV disease progression. (2006) (64)
The effect of HIV infection on overdose mortality (2005) (64)
Voluntary testing for human immunodeficiency virus (HIV) in a prison population with a high prevalence of HIV. (1994) (64)
Impact of increased syringe access: preliminary findings on injection drug user syringe source, disposal, and pharmacy sales in Harlem, New York. (2002) (64)
Prevention of HIV Infection in Street‐Recruited Injection Drug Users (2000) (64)
Human Immunodeficiency Virus Infection and Infective Endocarditis among Injecting Drug Users (1996) (63)
Urban health: a new discipline (2003) (63)
Prognostic indicators for development of AIDS among intravenous drug users. (1992) (63)
Discarded needles do not increase soon after the opening of a needle exchange program. (1997) (62)
Community-based programs for safe disposal of used needles and syringes. (1998) (62)
Use of HIV protease inhibitors is associated with left ventricular morphologic changes and diastolic dysfunction. (2002) (61)
Multiple Access to Sterile Syringes for Injection Drug Users: Vending Machines, Needle Exchange Programs and Legal Pharmacy Sales in Marseille, France (2001) (61)
Highly active antiretroviral treatment does not increase sexual risk behaviour among French HIV infected injecting drug users (2002) (61)
Syphilis serology in human immunodeficiency virus infection: evidence for false-negative fluorescent treponemal testing. (1997) (60)
Methodology for Evaluating a Partially Controlled Longitudinal Treatment Using Principal Stratification, With Application to a Needle Exchange Program (2004) (60)
Overdose deaths attributed to methadone and heroin in New York City, 1990-1998. (2004) (60)
Does Bleach Disinfection of Syringes Protect Against Hepatitis C Infection Among Young Adult Injection Drug Users? (2002) (60)
Handbook of urban health (2005) (60)
Patterns and predictors of trajectories of depression after an urban disaster. (2009) (60)
Human immunodeficiency virus 1 infection, cocaine, and coronary calcification. (2005) (60)
Dietary intake of community-based HIV-1 seropositive and seronegative injecting drug users. (1996) (60)
Differences in risk factors for human immunodeficiency virus type 1 seroconversion among male and female intravenous drug users. (1993) (59)
What explains the association between neighborhood-level income inequality and the risk of fatal overdose in New York City? (2006) (59)
The Impact of Multifocused Interventions on Sharps Injury Rates at an Acute-Care Hospital (1999) (59)
Gender differences in injection-related behaviors among injection drug users in Baltimore, Maryland. (1998) (59)
Hepatitis C incidence—a comparison between injection and noninjection drug users in New York City (2004) (58)
Determinants of influenza vaccination in hard-to-reach urban populations. (2006) (58)
Clinical characteristics and prognostic value of acute retroviral syndrome among injecting drug users (1995) (58)
Response to overdose among injection drug users. (2006) (58)
Instability of delayed-type hypersensitivity skin test anergy in human immunodeficiency virus infection. (1995) (58)
Evidence for HIV type 1 strains of U.S. intravenous drug users as founders of AIDS epidemic among intravenous drug users in northern Europe. (1996) (58)
Differences in the incidence of hepatitis B and human immunodeficiency virus infections among injecting drug users. (1996) (58)
An international collaborative study of the effects of coinfection with human T-lymphotropic virus type II on human immunodeficiency virus type 1 disease progression in injection drug users. (1996) (58)
Association between injection practices and duration of injection among recently initiated injection drug users. (2004) (57)
HIV Incidence Among Injection Drug Users in Baltimore, Maryland (1988-2004) (2006) (57)
Direct comparison of time to AIDS and infectious disease death between HIV seroconverter injection drug users in Italy and the United States: results from the ALIVE and ISS studies. AIDS Link to Intravenous Experiences. Italian Seroconversion Study. (1999) (56)
Behavioral risk exposure and host genetics of susceptibility to HIV-1 infection. (2006) (56)
HIV prevalence and risk behaviors among new initiates into injection drug use over the age of 40 years old. (1999) (56)
Variants in the Wilms' tumor gene are associated with focal segmental glomerulosclerosis in the African American population. (2005) (55)
Handbook of urban health : populations, methods, and practice (2005) (55)
Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial disease. (1996) (55)
Acquisition and use of needles and syringes by injecting drug users in Baltimore, Maryland. (1995) (54)
Strategies for Improving Influenza Immunization Rates among Hard-to-Reach Populations (2007) (54)
Cities and Health: History, Approaches, and Key Questions (2004) (54)
Perspectives on urban conditions and population health. (2005) (54)
Predictors of Peritraumatic Reactions and PTSD Following the September 11th Terrorist Attacks (2006) (53)
Effectiveness of highly active antiretroviral therapy among injection drug users with late-stage human immunodeficiency virus infection. (2005) (53)
The Relationships Between Sexual Behavior, Alcohol Use, and Personal Network Characteristics Among Injecting Drug Users in Baltimore, Maryland (1994) (53)
Prevalence and incidence of HIV among incarcerated and reincarcerated women in Rhode Island. (1999) (53)
Increase in sexual risk behavior associated with immunologic response to highly active antiretroviral therapy among HIV-infected injection drug users. (2004) (53)
The risk of transmission of HIV-1 through non-percutaneous, non-sexual modes--a review. (1990) (53)
Primary Care and Health Insurance among Women Released from New York City Jails (2006) (53)
Attitudes toward HIV treatments influence unsafe sexual and injection practices among injecting drug users (2003) (53)
Mortality Risk Among Recent-Onset Injection Drug Users in Five U.S. Cities (2008) (52)
Project VIVA: a multilevel community-based intervention to increase influenza vaccination rates among hard-to-reach populations in New York City. (2008) (52)
Cocaine injection and ethnicity in parenteral drug users during the early years of the human immunodeficiency virus (hiv) epidemic in new york city (1989) (52)
African HIV-1 subtype C and rate of progression among Ethiopian immigrants in Israel (1997) (51)
The relationship between non-injection drug use behaviors on progression to AIDS and death in a cohort of HIV seropositive women in the era of highly active antiretroviral therapy use. (2005) (51)
DRUG USER TREATMENT REFERRALS AND ENTRY AMONG PARTICIPANTS OF A NEEDLE EXCHANGE PROGRAM (2002) (51)
Trends in crime and the introduction of a needle exchange program. (2000) (51)
Infection with dual-tropic human immunodeficiency virus type 1 variants associated with rapid total T cell decline and disease progression in injection drug users. (1998) (50)
Trajectory and socioeconomic predictors of depression in a prospective study of residents of New York City. (2008) (50)
Intimate Partner Violence Perpetration and Condom Use-Related Factors: Associations with Heterosexual Men’s Consistent Condom Use (2009) (50)
Improvement of Anemia Among HIV‐Infected Injection Drug Users Receiving Highly Active Antiretroviral Therapy (2001) (49)
Stimulant Use and Progression to AIDS or Mortality After the Initiation of Highly Active Antiretroviral Therapy (2014) (49)
HIV Infection and Cognition in Intravenous Drug Users (1997) (49)
Income inequality and risk of suicide in New York City neighborhoods: a multilevel case-control study. (2005) (48)
Psychological Distress and Progression to AIDS in a Cohort of Injection Drug Users (2003) (48)
Economic conditions and suicide rates in New York City. (2012) (48)
Pharmacists' attitudes about pharmacy sale of needles/syringes and needle exchange programs in a city without needle/syringe prescription laws. (1998) (48)
Alcohol use and T-lymphocyte subsets among injection drug users with HIV-1 infection: a prospective analysis. (1996) (48)
Genetic influence of CXCR6 chemokine receptor alleles on PCP-mediated AIDS progression among African Americans (2003) (48)
Use of buprenorphine in HIV-infected injection drug users: negligible impact on virologic response to HAART. The Manif-2000 Study Group. (2000) (47)
Probable Cigarette Dependence, PTSD, and Depression after an Urban Disaster: Results from a Population Survey of New York City Residents 4 Months after September 11, 2001 (2005) (47)
Prevalence and Risk Factors for Bloodborne Exposure and Infection in Correctional Healthcare Workers (2007) (47)
Comparison of self-reported injection frequencies for past 30 days and 6 months among intravenous drug users. (1994) (47)
Highly active antiretroviral therapy associated with improved anemia among HIV-infected women. (2001) (47)
Persistence of Inconsistent Condom Use: Relation to Abuse History and HIV Serostatus (2004) (47)
Persistence and clinical significance of hepatitis G virus infections in injecting drug users. (1997) (47)
Human Immunodeficiency Virus Seroconversion and Evolution of the Hepatitis C Virus Quasispecies (2001) (47)
Dilated heart muscle disease associated with HIV infection. (1995) (47)
Cancer of the pancreas and drinking water: a population-based case-control study in Washington County, Maryland. (1992) (47)
Immunological effects of HIV-1 infection on the humoral response to malaria in an African population. (1989) (46)
Suicide in Older Adults in Long‐Term Care: 1990 to 2005 (2008) (46)
Hepatitis C virus infection among noninjecting drug users in New York City (2003) (46)
Clinical Effects of Synthetic Cannabinoid Receptor Agonists Compared with Marijuana in Emergency Department Patients with Acute Drug Overdose (2016) (45)
HIV‐1 infection and nervous system abnormalities among a cohort of intravenous drug users (1991) (45)
Changes in markers of disease progression in HIV-1 seroconverters: a comparison between cohorts of injecting drug users and homosexual men. (1995) (45)
Prevalence, incidence, and correlates of chlamydia and gonorrhea among young adult injection drug users. (2001) (45)
An analysis of tumor necrosis factor α gene polymorphisms and haplotypes with natural clearance of hepatitis C virus infection (2004) (45)
Prevalence and correlates of street-obtained buprenorphine use among current and former injectors in Baltimore, Maryland. (2013) (45)
Tuberculosis risk in funeral home employees. (1998) (45)
Impact of Drug Abuse Treatment Modalities on Adherence to ART/HAART Among a Cohort of HIV Seropositive Women (2008) (45)
HIV‐1 infection and intravenous drug use (1992) (45)
Prevalence of and risk factors for viral infections among human immunodeficiency virus (HIV)-infected and high-risk HIV-uninfected women. (2003) (45)
HEALTH SERVICES UTILIZATION BY INJECTION DRUG USERS PARTICIPATING IN A NEEDLE EXCHANGE PROGRAM (2002) (44)
Incidence of adverse cardiovascular events in adults following drug overdose. (2012) (44)
Sexual orientation and HIV infection prevalence among young Latino injection drug users in Harlem. (2001) (44)
Temporal trends of human immunodeficiency virus type 1 (HIV-1) infection among inmates entering a statewide prison system, 1985-1987. (1989) (43)
Dominant Effects of CCR2-CCR5 Haplotypes in HIV-1 Disease Progression (2004) (43)
Field effectiveness of needle disinfection among injecting drug users. (1994) (43)
Readmission risk factors after hospital discharge among the elderly. (2012) (43)
Progress in HIV Reduction and Prevention Among Injection and Noninjection Drug Users (2010) (43)
Association between intravenous drug use and early misbehavior. (1990) (43)
Preliminary evidence of health care provider support for naloxone prescription as overdose fatality prevention strategy in New York City (2003) (43)
Dynamics of SEN virus infection among injection drug users. (2001) (42)
Risk factors for severe respiratory depression from prescription opioid overdose (2018) (42)
Comparison between a whole blood interferon-gamma release assay and tuberculin skin testing for the detection of tuberculosis infection among patients at risk for tuberculosis exposure. (1999) (42)
Postcoital vaginal bleeding as a risk factor for transmission of the human immunodeficiency virus in a heterosexual partner study in Brazil. (1997) (42)
Prevalence and correlates of HIV, syphilis, and hepatitis B and C infection and harm reduction program use among male injecting drug users in Kabul, Afghanistan: A cross-sectional assessment (2011) (42)
Gender differences in sexual behaviors, sexual partnerships, and HIV among drug users in New York City (2006) (42)
Effect of chronic substance abuse on the neuropsychological performance of intravenous drug users with a high prevalence of HIV-1 seropositivity. (1992) (42)
Access to highly active antiretroviral therapy for injection drug users: adherence, resistance, and death. (2006) (42)
Skating on thin ice: stimulant use and sub‐optimal adherence to HIV pre‐exposure prophylaxis (2018) (41)
Longitudinal association of alcohol use with HIV disease progression and psychological health of women with HIV (2009) (41)
Longitudinal trends in hazardous alcohol consumption among women with human immunodeficiency virus infection, 1995-2006. (2009) (41)
Reducing drug use, human immunodeficiency virus risk, and recidivism among young men leaving jail: evaluation of the REAL MEN re-entry program. (2010) (41)
Alcohol use trajectories among adults in an urban area after a disaster: evidence from a population-based cohort study. (2008) (41)
Inadequate bleach contact times during syringe cleaning among injection drug users. (1994) (41)
Serologic evidence of rickettsialpox (Rickettsia akari) infection among intravenous drug users in inner-city Baltimore, Maryland. (1999) (40)
Factors associated with accelerated atherosclerosis in HIV-1-infected persons treated with protease inhibitors. (2003) (40)
High Prevalence of Iron Deficiency and Anemia Among Female Injection Drug Users With and Without HIV Infection (2002) (40)
Cities and the Health of the Public (2006) (40)
Mental Health in New York City After the September 11 Terrorist Attacks: Results From Two Population Surveys (2002) (39)
Heroin and Cocaine Dependence and the Risk of Accidental Non-Fatal Drug Overdose (2006) (39)
Routine surveillance for infections in nursing homes: experience at two facilities. (1987) (39)
Candidal Suppurative Peripheral Thrombophlebitis Recognition, Prevention, and Management (1986) (39)
A tumor necrosis factor-α-inducible promoter variant of interferon-γ accelerates CD4+ t cell depletion in human immunodeficiency virus-1-infected individuals (2003) (39)
Early immunologic and virologic responses to highly active antiretroviral therapy and subsequent disease progression among HIV-infected injection drug users (2007) (38)
Operation Red Box: a pilot project of needle and syringe drop boxes for injection drug users in East Baltimore. (1998) (38)
Incarceration and injection drug use in Baltimore, Maryland. (2015) (38)
Continuity of medical care and risk of incarceration in HIV-positive and high-risk HIV-negative women. (2002) (38)
Sampling and Recruitment in Multilevel Studies among Marginalized Urban Populations: The IMPACT Studies (2008) (38)
Identification of human immunodeficiency virus primary isolates resistant to interferon-alpha and correlation of prevalence to disease progression. (1995) (37)
The effect of hepatitis C on progression to AIDS before and after highly active antiretroviral therapy (2004) (37)
From Corrections to Communities as an HIV Priority (2006) (37)
The influence of drug use patterns on the rate of CD4+ lymphocyte decline among HIV‐1‐infected injecting drug users (1997) (37)
Comparison of PCR and hybrid capture methods for detection of human papillomavirus in injection drug-using women at high risk of human immunodeficiency virus infection (1997) (37)
Improved Antioxidant Status Among HIV‐Infected Injecting Drug Users on Potent Antiretroviral Therapy (2000) (37)
Comparison of clinical manifestations of HIV infection between male and female injecting drug users (1994) (37)
Ambient temperature and risk of death from accidental drug overdose in New York City, 1990-2006. (2010) (37)
Strategies That Promote Equity in COVID-19 Vaccine Uptake for Black Communities: a Review (2022) (37)
Readiness for Cessation of Drug Use Among Recent Attenders and Nonattenders of a Needle Exchange Program (2003) (37)
Sex-Specific Differences in Circumstances of Initiation into Injecting-Drug Use Among Young Adult Latinos in Harlem, New York City (2002) (36)
Navigating non-positivity in neighbourhood studies: an analysis of collective efficacy and violence (2012) (36)
Factors Associated with Differential Uptake of Seasonal Influenza Immunizations Among Underserved Communities During the 2009–2010 Influenza Season (2012) (36)
Characteristics of injection drug using parents who retain their children. (2001) (36)
Collaboration among community members, local health service providers, and researchers in an urban research center in Harlem, New York. (2001) (35)
Multidrug-resistant tuberculosis. (1992) (35)
Human immunodeficiency virus infection in diabetic intravenous drug users. (1991) (35)
Health care utilization among young adult injection drug users in Harlem, New York. (2001) (35)
Variation in Risk for Falls by Clinical Department: Implications for Prevention (1990) (35)
Dynamics of behavioral risk factors for HIV/AIDS: a 6-year prospective study of injection drug users. (2001) (34)
Utility of serum lactate to predict drug-overdose fatality (2010) (34)
Comparison of clinical symptoms of human immunodeficiency virus disease between intravenous drug users and homosexual men. (1993) (34)
Effect of cocaine use on coronary calcium among black adults in Baltimore, Maryland. (2002) (34)
Changes in Willingness to Participate in HIV Vaccine Trials Among HIV-Negative Injection Drug Users (2005) (33)
Consistent Effects of TSG101 Genetic Variability on Multiple Outcomes of Exposure to Human Immunodeficiency Virus Type 1 (2006) (33)
Coinfection with tuberculosis and HIV-1 in male prison inmates. (1990) (33)
Comparing New Participants of a Mobile Versus a Pharmacy‐Based Needle Exchange Program (2000) (33)
Community incidence of hepatitis B and C among reincarcerated women. (2005) (33)
HIV seroconversion and disinfection of injection equipment among intravenous drug users, Baltimore, Maryland. (1991) (33)
Prevention of HIV infection in street-recruited injection drug users. The Collaborative Injection Drug User Study (CIDUS). (2000) (33)
New York City pharmacists' attitudes toward sale of needles/syringes to injection drug users before implementation of law expanding syringe access (2000) (32)
Effect of Micronutrients and Iron Supplementation on Hemoglobin, Iron Status, and Plasma Hepatitis C and HIV RNA Levels in Female Injection Drug Users: A Controlled Clinical Trial (2007) (32)
Alcohol Consumption Trajectory Patterns in Adult Women with HIV Infection (2013) (32)
Urban health: global perspectives. (2010) (32)
Incidence and risk factors for human T-lymphotropic virus type II seroconversion among injecting drug users in Baltimore, Maryland, U.S.A. (1995) (32)
Risk factors for methadone outside treatment programs: implications for HIV treatment among injection drug users. (2007) (32)
HIV testing behaviors in a population of inner-city women at high risk for HIV infection. (1996) (31)
Heat-denatured human immunodeficiency virus type 1 protein 24 antigen: prognostic value in adults with early-stage disease. (2002) (31)
The Effect of RANTES Chemokine Genetic Variants on Early HIV-1 Plasma RNA Among African American Injection Drug Users (2005) (31)
Investigating the effect of social changes on age-specific gun-related homicide rates in New York City during the 1990s. (2010) (31)
Explaining the relationship between race/ethnicity and pharmacy purchased syringes among injection drug users in New York City. (2004) (30)
High-Risk Behavior and Potential Transmission of Drug-Resistant HIV Among Injection Drug Users (2004) (30)
Ecstasy use and its Association with Sexual Behaviors Among Drug Users in New York City (2005) (30)
The influence of a major disaster on suicide risk in the population. (2009) (30)
Comparison of neuropsychological performance between AIDS-free injecting drug users and homosexual men. (1997) (30)
The effect of latent Mycobacterium tuberculosis infection on human immunodeficiency virus (HIV) disease progression and HIV RNA load among injecting drug users. (1996) (30)
Resilient children of injection drug users. (2004) (30)
Interpersonal predictors of depression trajectories in women with HIV. (2005) (30)
Education inequality and use of cigarettes, alcohol, and marijuana. (2004) (30)
Use of audio computer-assisted self-interviews to assess tuberculosis-related risk behaviors. (2001) (29)
Normative data for a brief neuropsychologic test battery in a cohort of injecting drug users. (1995) (29)
Diversification of subtype E human immunodeficiency virus type 1 env in heterosexual seroconverters from Northern Thailand. (1998) (29)
Maturity of human immunodeficiency virus infection and incubation period of acquired immunodeficiency syndrome in injecting drug users. (1994) (29)
Acceptance and completion of hepatitis B vaccination among drug users in New York City. (2004) (29)
Incidence of violence against HIV-infected and uninfected women: Findings from the HIV epidemiology research (HER) study (2002) (29)
Education inequality and use of cigarettes, alcohol, and marijuana (2007) (29)
Use of sterile syringes and aseptic drug preparation are important components of HIV prevention among injection drug users. (1998) (29)
Relationship of self-reported asthma severity and urgent health care utilization to psychological sequelae of the September 11th attacks among New York City area residents (2003) (29)
Clinical risk factors for in-hospital adverse cardiovascular events after acute drug overdose. (2015) (28)
Drugs and firearm deaths in New York City, 1990–1998 (2002) (28)
Drug-related behavior change for HIV transmission among American injection drug users. (1994) (28)
Confidence and Hesitancy During the Early Roll-out of COVID-19 Vaccines Among Black, Hispanic, and Undocumented Immigrant Communities: a Review (2021) (28)
Alcohol Drinking Problems Among New York City Residents after the September 11 Terrorist Attacks (2006) (28)
Temporal trends of initial CD4 cell counts following human immunodeficiency virus seroconversion in Italy, 1985-1992. The Human Immunodeficiency Virus Italian Seroconversion Study. (1996) (28)
New evidence to reconcile in vitro and epidemiologic data on the possible role of heroin on CD4+ decline among HIV-infected injecting drug users. (1999) (28)
Beyond income: material resources among drug users in economically-disadvantaged New York City neighborhoods. (2012) (27)
Needle-exchange participation, effectiveness, and policy: Syringe relay, gender, and the paradox of public health (2001) (27)
Direct comparison of the relationship between clinical outcome and change in CD4+ lymphocytes in human immunodeficiency virus-positive homosexual men and injecting drug users. (1994) (27)
Correlates of attitudes concerning human immunodeficiency virus and acquired immunodeficiency syndrome among hospital workers. (1994) (27)
Psychological Resilience After Disaster York City in the Aftermath of the September 11th (2006) (27)
Understanding Prolonged Cessation from Heroin Use: Findings from a Community-Based Sample (2014) (27)
Snake bite and antivenom complications in Belo Horizonte, Brazil. (1994) (27)
Opioid Receptor Polymorphism A118G Associated with Clinical Severity in a Drug Overdose Population (2013) (27)
Effect of zinc and vitamin A supplementation on antibody responses to a pneumococcal conjugate vaccine in HIV-positive injection drug users: a randomized trial. (2006) (27)
Racial/ethnic differences in screening for colon cancer: report from the New York Cancer Project. (2005) (26)
Interest in HIV vaccines among injection drug users in Baltimore, Maryland. (1994) (26)
Long-term perspective on the prevalent-cohort biases in studies of human immunodeficiency virus progression. (1997) (26)
Risk of Tuberculosis in Correctional Healthcare Workers (2005) (26)
Powering population health research: Considerations for plausible and actionable effect sizes (2021) (26)
MICA and recovery from hepatitis C virus and hepatitis B virus infections (2004) (26)
Roundtable on Urban Living Environment Research (RULER) (2011) (26)
Drug use frequency among street-recruited heroin and cocaine users in harlem and the bronx before and after September 11, 2001 (2002) (26)
Improvement of anemia among HIV-infected injection drug users receiving highly active antiretroviral therapy (2001) (26)
Comparison of HIV infection risk behaviors among injection drug users from East and West Coast US cities (2004) (26)
Feasibility of referring drug users from a needle exchange program into an addiction treatment program: experience with a mobile treatment van and LAAM maintenance. (2003) (26)
Leadership by collaboration: Nursing's bold new vision for academic-practice partnerships. (2017) (25)
Selective transmission of human immunodeficiency virus type 1 variants to SCID mice reconstituted with human peripheral blood monoclonal cells (1996) (25)
Pre-AIDS mortality and morbidity among injection drug users in Amsterdam and Baltimore: an ecological comparison. (1999) (25)
The practice of 'frontloading' among intravenous drug users: association with HIV-antibody. (1991) (25)
Barriers and missed opportunities in breast and cervical cancer screening among women aged 50 and over, New York City, 2002. (2007) (25)
Elevated C-reactive protein levels are associated with endothelial dysfunction in chronic cocaine users. (2003) (25)
Detection of human immunodeficiency virus type 1 infection by polymerase chain reaction in a cohort of seronegative intravenous drug users. (1993) (25)
Long-Term Effectiveness of Diagnosing and Treating Latent Tuberculosis Infection in a Cohort of HIV-Infected and At-Risk Injection Drug Users (2008) (25)
Needle Exchange Programs and Experience of Violence in an Inner City Neighborhood (2001) (24)
Transparent Reporting of Evaluations with Nonrandomized Designs (TREND) (2004) (24)
Self-reported bacterial infections among women with or at risk for human immunodeficiency virus infection. (1999) (24)
Hiv Knowledge and Attitudes among Intravenous Drug Users: Comparisons to the U.S. Population and by Drug Use Behaviors (1991) (24)
HIV and proteinuria in an injection drug user population. (2010) (24)
Intimate Partner Violence and Consistent Condom Use Among Drug-Using Heterosexual Women in New York City (2010) (24)
Physical activity in a cohort of HIV-positive and HIV-negative injection drug users (2006) (23)
Correlates of human immunodeficiency virus infection in intravenous drug users: are treatment-program samples misleading? (1992) (23)
Clinical and Immunologic Progression in HIV‐Infected US Women Before and After the Introduction of Highly Active Antiretroviral Therapy (2003) (23)
The Role of Community–Academic Partnerships: Implications for Medical Education, Research, and Patient Care (2008) (23)
Children of HIV-positive drug-using parents. (2003) (23)
Recent infection with human immunodeficiency virus and possible rapid loss of CD4 T lymphocytes. (1995) (23)
Epidemiology of subway-related fatalities in New York City, 1990-2003. (2008) (23)
Perspectives on infection with HIV-1 among intravenous drug users. (1988) (23)
A comparison of HIV seropositive and seronegative young adult heroin- and cocaine-using men who have sex with men in New York City, 2000–2003 (2005) (22)
Validation of the Prognostic Utility of the Electrocardiogram for Acute Drug Overdose (2017) (22)
Alternative causal inference methods in population health research: Evaluating tradeoffs and triangulating evidence (2019) (22)
More pharmacists in high-risk neighborhoods of New York City support selling syringes to injection drug users. (2002) (22)
Prognostic Factors for Survival Differ According to CD4+ Cell Count Among HIV-Infected Injection Drug Users: Pre-HAART and HAART Eras (2005) (22)
Longitudinal Study of Condom Use Patterns Among Women With or at Risk for HIV (2001) (22)
Drug and alcohol use as determinants of New York City homicide trends from 1990 to 1998. (2005) (22)
Characteristics of injection drug users who utilize tuberculosis services at sites of the baltimore city needle exchange program (2002) (22)
Pharmacy access to sterile syringes for injection drug users: attitudes of participants in a syringe exchange program. (1999) (22)
Ecstasy Use Among Hispanic and Black Substance Users in New York City (2005) (22)
Characteristics of Intravenous Drug Users by History of Arrest and Treatment for Drug Use (1992) (22)
Diagnosis and differentiation of HTLV-I and HTLV-II infection by enzyme immunoassays using synthetic peptides. (1991) (22)
Club Drug Use Among Minority Substance Users in New York City (2004) (22)
Decline in Self-Reported High-Risk Injection-Related Behaviors Among HIV-Seropositive Participants in the Baltimore Needle Exchange Program (2000) (22)
Seasonal and annual variation of antibody to HIV-1 among male inmates entering Maryland prisons: update. (1990) (22)
Psychological sequelae of the September 11th attacks in Manhattan, New York City. (2002) (22)
Mental health status among ethnic Albanians seeking medical care in an emergency department two years after the war in Kosovo: a pilot project. (2004) (21)
Self-efficacy estimates for drug use practices predict risk reduction among injection drug users (2002) (21)
Impact of expanding syringe access in New York on sources of syringes for injection drug users in Harlem and the Bronx, NYC, USA (2003) (21)
Awareness and perceptions of a communitywide mental health program in New York city after September 11. (2003) (21)
Changes in HIV Risk Behaviors among Counseled Injecting Drug Users (1994) (21)
Pediatric Prehospital Evaluation of NYC Cardiac Arrest Survival (PHENYCS) (2012) (21)
Correlates of Unsafe Syringe Acquisition and Disposal Among Injection Drug Users in Baltimore, Maryland (2005) (21)
Medical examiner and medical toxicologist agreement on cause of death. (2011) (21)
HTLV‐II and Bacterial Infections Among Injection Drug Users (2000) (21)
Syringe exchange not associated with social network formation: results from Baltimore (2000) (21)
Syringe Disposal Among Injection Drug Users in Harlem and the Bronx During the New York State Expanded Syringe Access Demonstration Program (2007) (21)
War-related psychological sequelae among emergency department patients in the former Republic of Yugoslavia (2004) (21)
Physical activity in a cohort of HIV-positive and HIV-negative injection drug users. (2005) (20)
A Community Responds to the COVID-19 Pandemic: a Case Study in Protecting the Health and Human Rights of People Who Use Drugs (2020) (20)
An Investigation of the Psychological Effects of the September 11, 2001, Attacks on New York City: Developing and Implementing Research in the Acute Postdisaster Period (2002) (20)
Introduction: New dynamics of HIV risk among drug-using men who have sex with men (2005) (20)
Haplotype analysis of the SDF-1 (CXCL12) gene in a longitudinal HIV-1/AIDS cohort study (2005) (20)
Longitudinal population-based studies of affective disorders: Where to from here? (2008) (20)
Immune serum markers and CD4 cell counts in HIV-infected intravenous drug users. (1992) (20)
Aids knowledge and risk perceptions among Pennsylvania prisoners (1991) (20)
Comparison of clinical manifestations of HIV infection among women by risk group, CD4+ cell count, and HIV-1 plasma viral load. HER Study Group. HIV Epidemiology Research. (1999) (20)
HIV Risk Behaviors Among Young Drug Using Women Who Have Sex With Women (WSWs) in New York City (2011) (20)
Hepatitis B vaccination in correctional health care workers. (2005) (20)
Idiopathic chronic fatigue and chronic fatigue syndrome: a comparison of two case-definitions. (1999) (19)
Racial susceptibility for QT prolongation in acute drug overdoses. (2014) (19)
Occupational risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infections among funeral service practitioners in Maryland. (1995) (19)
Differing Risk Factors for Cerebral Palsy in the Presence of Mental Retardation and Epilepsy (1999) (19)
Existence and failure of T-cell homeostasis prior to AIDS onset in HIV-infected injection drug users. (1996) (19)
Comparing new participants of a mobile versus a pharmacy-based needle exchange program. (2000) (19)
Television Watching and Mental Health in the General Population of New York City After September 11 (2004) (19)
Clinical characteristics and prognostic value of acute retroviral syndrome among injecting drug users. Italian Seroconversion Study. (1995) (19)
Frequency of left ventricular dysfunction and other echocardiographic abnormalities in human immunodeficiency virus seronegative intravenous drug users. (1993) (19)
Evaluating supervised haart in late-stage HIV among drug users: A preliminary report (1999) (19)
Feasibility, Acceptability, and Tolerability of Targeted Naltrexone for Nondependent Methamphetamine-Using and Binge-Drinking Men Who Have Sex with Men (2016) (19)
Syphilis in injecting drug users: clues for high-risk sexual behaviour in female IDUs (1997) (18)
Variation in risk for falls by clinical department: implications for prevention. (1990) (18)
Haplotype diversity in the interleukin-4 gene is not associated with HIV-1 transmission and AIDS progression (2003) (18)
The Impact of Syringe Deregulation on Sources of Syringes for Injection Drug Users: Preliminary Findings (2006) (18)
Suicide Tourism in Manhattan, New York City, 1990–2004 (2007) (18)
Blood and plasma donations among a cohort of intravenous drug users. (1990) (18)
The effects of illicit drug use and HIV infection on sex hormone levels in women (2006) (18)
Utility of Cardiac Troponin to Predict Drug Overdose Mortality (2016) (18)
Research on Trauma and PTSD in the Aftermath of 9/11 (2004) (18)
The role of epidemiology in needle exchange programs. (2000) (18)
Changes in Hepatitis C Virus (HCV) Viral Load and Interferon-&agr; Levels in HIV/HCV-Coinfected Patients Treated With Highly Active Antiretroviral Therapy (2006) (17)
A pilot syringe exchange program in Washington, DC. (1994) (17)
Factors Associated With Human Herpesvirus Type 8 Infection in an Injecting Drug User Cohort (2003) (17)
Validity of self-reported needle exchange attendance among injection drug users: implications for program evaluation. (2002) (17)
A Framework for the Study of Urban Health (2006) (17)
Potential use of mass media to reach urban intravenous drug users with AIDS prevention messages. (1993) (17)
Comparison of Two Measures of Human Immunodeficiency Virus (HIV) Type 1 Load in HIV Risk Groups (1998) (17)
Self-Reported Reasons for Needle Sharing and Not Carrying Bleach among Injection Drug Users in Baltimore, Maryland (1995) (17)
Personal Network Correlates and Predictors of Homelessness for Injection Drug Users in Baltimore, Maryland (1998) (16)
Changes in sexual and drug-related risk behavior following antiretroviral therapy initiation among HIV-infected injection drug users (2012) (16)
The evaluation of needle exchange programs. (1994) (16)
Age, gender, and other predictors of the wasting syndrome among HIV-1-infected injecting drug users. (1995) (16)
HIV-1 Infection In The Correctional Setting (1990) (16)
Prognostic Utility of Initial Lactate in Patients With Acute Drug Overdose: A Validation Cohort (2018) (16)
Community support for needle exchange programs and pharmacy sale of syringes: a household survey in Baltimore, Maryland. (1998) (15)
Human immunodeficiency virus type 1 env and p17gag sequence variation in polymerase chain reaction-positive, seronegative injection drug users. (1995) (15)
Integration of buprenorphine for substance-abuse treatment by HIV care providers. (2011) (15)
Elevated serum levels of neopterin but not β2‐microglobulin in HIV‐1‐seronegative injecting drug users (1993) (15)
Controlled clinical evaluation of diacetyl morphine for treatment of intractable opiate dependence (1999) (15)
Factors Associated with Initiation of Zidovudine in a Cohort of Injection Drug Users (1995) (15)
Collaboration among Community Members, Local Health Service Providers, and Researchers in an Urban Research Center in Harlem, New York (2001) (15)
Correlates of illicit methadone use in New York City: A cross-sectional study (2008) (15)
Profile of HIV seropositive inmates diagnosed in Maryland's state correctional system. (1994) (15)
The Relationship Between Self-Reported Sexual Orientation and Behavior in a Sample of Middle-Aged Male Injection Drug Users (2006) (15)
Injection Drug Use Is an Independent Risk Factor for Iron Deficiency and Iron Deficiency Anemia Among HIV-Seropositive and HIV-Seronegative Women (2005) (15)
Health behaviors and occupational stress of Brazilian civil servants living in an urban center. (2013) (15)
Prevalence and Correlates of Previous Hepatitis B Vaccination and Infection Among Young Drug-users In New York City (2008) (15)
The effect of drug-injection behavior on genetic evolution of HIV-1. (1999) (14)
Hepatitis C and HIV incidence and harm reduction program use in a conflict setting: an observational cohort of injecting drug users in Kabul, Afghanistan (2015) (14)
Sex-based differences in T lymphocyte responses in HIV-1-seropositive individuals. (2005) (14)
Previous Cancer Screening Behavior as Predictor of Endoscopic Colon Cancer Screening Among Women Aged 50 and Over, in NYC 2002 (2008) (14)
Postcoital vaginal bleeding as a risk factor for transmission of the human immunodeficiency virus in a heterosexual partner study in Brazil. Rio de Janeiro Heterosexual Study Group. (1997) (14)
Regional variation in CCR5-Δ32 gene distribution among women from the US HIV Epidemiology Research Study (HERS) (2002) (14)
Impact of Needle Exchange Programs on Adolescent Perceptions About Illicit Drug Use (2001) (14)
Preparations for AIDS vaccine trials. Incident human immunodeficiency virus (HIV) infections in a cohort of injection drug users in Baltimore, Maryland. (1994) (14)
Health services: #66 Access to psychiatric services in new york city following the septemer 11th terrorist attacks (2002) (14)
Prevalence of cryoglobulinemia in hepatitis C virus (HCV) positive patients with and without human immunodeficiency virus (HIV) coinfection. (2004) (13)
A pivotal moment for urban health. (2015) (13)
Improved antioxidant status among HIV-infected injecting drug users on potent antiretroviral therapy. (2000) (13)
Urban Health: Populations, methods, and practice (2006) (13)
Toward an urban health advantage. (2005) (13)
Deregulation of the sale and possession of syringes for HIV prevention among injection drug users. (1995) (13)
Criteria for assessing cutaneous anergy in women with or at risk for HIV infection. HIV Epidemiologic Research Study Group. (1999) (13)
HIV seroconversion studies among intravenous drug users. (1994) (13)
Risk factors and cumulative incidence of anaemia among HIV-infected injection drug users (2002) (13)
Maryland inmates' knowledge of HIV-1 transmission and prevention; a comparison with the U.S. general population (1990) (13)
Rapid Vaccine Distribution in Nontraditional Settings: Lessons Learned From Project VIVA (2007) (13)
Cardiovascular disease risk assessment and prevention in blood donors (2012) (13)
Impact of drug treatment on subsequent sexual risk behavior in a multisite cohort of drug-using women: a report from the Women's Interagency HIV Study. (2005) (13)
Vitamin A levels and human immunodeficiency virus load in injection drug users (1997) (13)
Neighborhood Characteristics and Sexual Intimate Partner Violence Against Women Among Low-Income, Drug-Involved New York City Residents (2014) (13)
Household bleach as disinfectant for use by injecting drug users (1993) (13)
No Data, No Problem, No Action: Addressing Urban Health Inequity in the 21st Century (2011) (12)
Urbanicity, Urbanization, and the Urban Environment (2007) (12)
Access to Resources for Substance Users in Harlem, New York City: Service Provider and Client Perspectives (2002) (12)
On antibiotic prophylaxis in cardiac surgery: a risk factor for wound infection. (1986) (12)
Neurosurgical Wound Infections: Methodological and Clinical Factors Affecting Calculation of Infection Rates (1984) (12)
What to Do When Everything Happens at Once: Analytic Approaches to Estimate the Health Effects of Co-Occurring Social Policies (2020) (12)
Multiperson Use of Syringes Among Injection Drug Users in a Needle Exchange Program: A Gene-Based Molecular Epidemiologic Analysis (2006) (12)
Tetanus and injections drug use: Rediscovery of a neglected problem? (1996) (12)
Challenges to an integrated population health research agenda: Targets, scale, tradeoffs and timing. (2016) (12)
Strategies that Promote Equity in COVID-19 Vaccine Uptake for Undocumented Immigrants: A Review (2022) (12)
Influence of Injection Drug Use Behavior on Reported Antiretroviral Therapy Use Among Women in the HIV Epidemiology Research Study: On‐Site Versus Referral Care (2001) (12)
Development of a “Survival” Guide for Substance Users in Harlem, New York City (2002) (12)
Gonorrhea Prevalence in the Maryland State Prisons (1989) (12)
HIV testing and retesting for men and women in Switzerland (2000) (11)
Drug Dependence among Young Recently Initiated Injection Drug Users (2002) (11)
Support for Buprenorphine and Methadone Prescription to Heroin-Dependent Patients among New York City Physicians (2006) (11)
The Revolution Will Be Hard to Evaluate: How Co-Occurring Policy Changes Affect Research on the Health Effects of Social Policies (2020) (11)
The relationship between genotypic sensitivity score and treatment outcomes in late stage HIV disease after supervised HAART (2009) (11)
Needle-cleaning practices among intravenous drug users who share injection equipment in Baltimore, Maryland. (1992) (11)
Erratum: Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10 (Proceedings of the National Academy of Sciences of the United States of America (2000) 97:26 (14467-14472)) (2001) (10)
Seoul hantavirus seropositivity among injecting drug users in Baltimore. (1994) (10)
Improving survival among HIV-infected injection drug users: how should we define success? (2007) (10)
New York State pharmacists' attitudes toward needle and syringe sales to injection drug users before implementation of syringe deregulation (2000) (10)
PANEL ON NEEDLE EXCHANGE AND BLEACH DISTRIBUTION PROGRAMS (1995) (10)
Adherence and Retention of Female Injection Drug Users in a Phase III Clinical Trial in Inner City Baltimore (2007) (10)
Cell-associated infectious HIV-1 viral load as a predictor of clinical progression and survival among HIV-1 infected injection drug users and homosexual men (1999) (10)
Mycobacterium tuberculosis infection and disease are not associated with protection against subsequent disseminated M. avium complex disease (1998) (10)
Spatial analytic approaches to explaining the trends and patterns of drug overdose deaths (2008) (9)
Syringe distribution to injection drug users for prevention of HIV infection: opinions and practices of health care providers in New York City. (2004) (9)
Development of Quantitative Research Skills Competencies to Improve Doctor of Philosophy Nursing Student Training. (2018) (9)
Resources and Interest Among Faith Based Organizations for Influenza Vaccination Programs (2013) (9)
Evaluation of possible effects of continued drug use on HIV progression among women. (2004) (9)
A tumor necrosis factor-alpha-inducible promoter variant of interferon-gamma accelerates CD4+ T cell depletion in human immunodeficiency virus-1-infected individuals. (2003) (9)
Post-traumatic stress symptoms in the general population after a disaster: Implications for public health (2006) (9)
Further experience with the World Health Organization clinical case definition for AIDS in Uganda. (1989) (9)
Palliative care for HIV disease in the era of highly active antiretroviral therapy (2000) (9)
Access To Influenza Vaccine In East Harlem And The Bronx During A National Vaccine Shortage (2007) (9)
Antibody to Human T‐Lymphotropic Virus Type I/II (HTLV‐I/II) Among Male Inmates Entering Maryland Prisons (1990) (9)
Understanding the dynamics of sexual transmission of HIV among drug-using populations: An integration of biological, behavioral, and environmental perspectives (2003) (9)
Terminology for drug injection practices among intravenous drug users in Baltimore. (1992) (8)
Protozoan-Viral-Bacterial Co-Infections Alter Galectin Levels and Associated Immunity Mediators in the Female Genital Tract (2021) (8)
A Focus Group Evaluation of Drop Boxes for Safe Syringe Disposal (1998) (8)
Bayesian Hierarchical Spatial Modeling of Substance Abuse Patterns Following a Mass Trauma: The Role of Time and Place (2009) (8)
Self-reported increase in asthma severity following the September 11 attack on the World Trade Center, Manhattan, New York-2001 (2002) (8)
Validation of the proposed World Health Organization staging system for HIV disease and infection in a cohort of intravenous drug users (1994) (8)
Why don't intravenous drug users use condoms? (1989) (8)
The Nonimpact of the Expanded Syringe Access Program upon Heroin Use, Injection Behaviours, and Crime Indicators in New York City and State (2006) (7)
Individual and Neighborhood Characteristics Associated with HIV Among Black and Latino Adults Who Use Drugs and Unaware of Their HIV-Positive Status, New York City, 2000–2004 (2016) (7)
Sensitivity analysis using elicited expert information for inference with coarsened data: illustration of censored discrete event times in the AIDS Link to Intravenous Experience (ALIVE) Study. (2008) (7)
HIV infection risk to nonhealth-care workers. (1990) (7)
The Role of Medicaid HMO Enrollment in the Longitudinal Utilization of Medical Care Services in a Cohort of Injecting Drug Users in Baltimore, Maryland (2003) (7)
A Morphine Prescription Program in Italy (1980-1985): Retrospective Evidence of Protection Against Hiv/Aids (1997) (7)
Harm Reduction, By Mail: the Next Step in Promoting the Health of People Who Use Drugs (2021) (7)
Helper T-lymphocyte count. TRAx CD4 test kit versus conventional flow cytometry. (1997) (7)
Mortality among persons who inject drugs: A prospective cohort followed over three decades in Baltimore, Maryland, USA. (2021) (7)
Retinoids and drugs of abuse: implications for neurological disease risk in human immunodeficiency virus type 1 infection. (2003) (7)
Impact of conflict and displacement on risk behaviours amongst people who inject drugs in Kabul, Afghanistan. (2016) (7)
Preventing HIV Transmission (1995) (7)
Transmission of human immunodeficiency virus within the health care setting. (1987) (7)
Slum health in Bangladesh: insights from health and demographic surveillance (2019) (6)
Comparison of HIV Risk by Duration of Injection Drug Use (2011) (6)
Urban disaster: a population perspective (2002) (6)
Improved Detection of HTLV‐II Antibody Using a Whole Viral Lysate‐Based EIA (1994) (6)
Sexual Risk Behavior Among Injection Drug Users Before Widespread Availability of Highly Active Antiretroviral Therapy (2005) (6)
Increased Frequency of Overdose Deaths Among HIV-Infected Injection Drug Users (2000) (6)
Invited commentary: Considering bias in the assessment of respiratory symptoms among residents of Lower Manhattan following the events of September 11, 2001. (2005) (6)
Interest in HIV vaccines among Italian injection drug users. The Network Interregionale SERT. (1995) (6)
Predictors of Influenza Vaccination in an Urban Community during a National Shortage (2008) (6)
HCV Infection and Cryptogenic Cirrhosis are Risk Factors for Hepatocellular Carcinoma Among Latinos in New York City (2009) (6)
New York City, 2001: Reaction and response (2002) (6)
Short tandem repeat methodology for genotypic identification of single-person versus multi-person use of syringes (2000) (6)
Re: "High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: results of a cohort study". (1999) (5)
What We Can Learn From the INSPIRE Study About Improving Prevention and Clinical Care for Injection Drug Users Living With HIV (2007) (5)
Preferences for pre-exposure prophylaxis among U.S. military men who have sex with men: results of an adaptive choice based conjoint analysis study (2021) (5)
The Effects of Needle Exchange Programs (1995) (5)
Period and birth-cohort effects on age of first phencyclidine (PCP) use among drug users in New York City, 1960 to 2000. (2006) (5)
Body habitus in a cohort of HIV-seropositive and HIV-seronegative injection drug users. (2005) (5)
Impacts of Medical Marijuana Laws on Young Americans Across the Developmental Spectrum (2019) (5)
Correction to: Slum Health: Arresting COVID-19 and Improving Well-Being in Urban Informal Settlements (2021) (5)
The revolution will be hard to evaluate: How simultaneous change in multiple policies affects policy-based health research (2020) (5)
Relationship between HIV‐1 viral load and continued drug use in untreated infected injection drug users (1999) (5)
Integrating HIV Prevention Activities into the HIV Medical Care Setting: A Report from the NYC HIV Centers Consortium (2006) (5)
Liver enzyme values in injection drug users with chronic hepatitis C. (2005) (5)
HIV/HTLV-II coinfection and CD4+ cell count controlling for plasma HIV viral load in injection drug users in Baltimore. (1998) (5)
Multi-level intersectional stigma reduction intervention to increase HIV testing among men who have sex with men in Ghana: Protocol for a cluster randomized controlled trial (2021) (5)
Federal requirements for nursing homes to include certified nursing assistants in resident care planning and interdisciplinary teams: A policy analysis. (2021) (5)
Erratum: Building and sustaining community-institutional partnerships for prevention research: Findings from a national collaborative (Journal of Urban Health DOI: 10.1007/s11524-006-9113-y) (2007) (5)
Building the evidence on Making Health a Shared Value: Insights and considerations for research (2019) (5)
Hepatitis C Reinfection in People Who Inject Drugs in Resource-Limited Countries: A Systematic Review and Analysis (2020) (5)
Elevated serum levels of neopterin but not beta 2-microglobulin in HIV-1-seronegative injecting drug users. (1993) (5)
Creating healthier cities: Where Do We Go from here? (2006) (4)
Inference for cumulative incidence functions with informatively coarsened discrete event‐time data (2008) (4)
Urban neighborhood socioeconomic status and incidence of depression: Evidence from a population-based cohort study (2007) (4)
Heterogeneous treatment effects in social policy studies: An assessment of contemporary articles in the health and social sciences (2022) (4)
Geographic variation in HIV infection among injecting drug users with Barcelona. (1995) (4)
Nutrition/behavior/psychiatric (2002) (4)
Drug use. Vancouver Conference Review. (1997) (4)
The Epidemiology of HIV and AIDS (1995) (4)
Neighborhood characteristics, trauma, and the risk of post-traumatic stress disorder in New York City (2004) (4)
Epidemiology and Urban Health Research (2005) (4)
Strategies That Promote Equity in COVID-19 Vaccine Uptake for Latinx Communities: a Review (2022) (4)
The effect of immunodeficiency on cutaneous delayed-type hypersensitivity testing in HIV-infected women without anergy: implications for tuberculin testing. HER Study Group. HIV Epidemiology Research. (1999) (4)
Global infectious diseases and urbanization. (2010) (4)
Commentary: Modelling and understanding differences in human immunodeficiency and hepatitis C virus epidemiology in injection drug users. (2003) (4)
HIV sero disclosure among men who have sex with men and transgender women on HIV pre-exposure prophylaxis (2018) (4)
Pediatric Prehospital Evaluation of NYC Respiratory Arrest Survival (PHENYCS) (2012) (4)
Telephone-based research methods (2006) (4)
HIV vaccines for injection drug users in the context of a comprehensive prevention agenda. (1994) (4)
Analytic methods for estimating the health effects of social policies in the presence of simultaneous change in multiple policies: A review (2020) (4)
Durable Viral Suppression Among People Living with HIV who Inject Drugs from a Community-Based Cohort in Baltimore, Maryland, 1997-2017. (2019) (4)
Does Bleach Disinfection of Syringes Help Prevent Hepatitis C Virus Transmission (2003) (3)
Feasibility and acceptability of intensive, real-time biobehavioral data collection using ecological momentary assessment, salivary biomarkers, and accelerometers among middle-aged African Americans. (2020) (3)
Suicidal ideation among African-American non-injection drug users. (2005) (3)
The Second Annual International Conference on Urban Health (2003) (3)
HIV infection risk to health-care workers. (1990) (3)
Occupationally Acquired Human Immunodeficiency Virus-1 Infection in Health Care Workers: A Review (1990) (3)
Changing living conditions; Changing health U.S. Cities since world war II (2006) (3)
Erratum: Prevalence and incidence of HIV, Hepatitis B virus, and Hepatitis C virus infections among males in Rhode Island prisons (American Journal of Public Health (2004) 94 (1218-1223)) (2004) (3)
The Present and Future of Cities (2019) (3)
Racial Discrimination, Sedentary Time, and Physical Activity in African Americans: Quantitative Study Combining Ecological Momentary Assessment and Accelerometers (2021) (3)
Epidemiologic research and disasters. (2004) (3)
Cities and infectious diseases: Controls and challenges (2006) (3)
Household bleach as disinfectant for use by injecting drug users. (1993) (3)
Building the Evidence Base to Prevent Firearm Deaths and Injuries (2018) (3)
Reducing Disparities in Vaccination Rates Between Different Racial/Ethnic and Socioeconomic Groups: The Potential of Community‐based Multilevel Interventions (2005) (3)
War and anxiety disorders. (2004) (3)
Correction to: Eviction, Health Inequity, and the Spread of COVID-19: Housing Policy as a Primary Pandemic Mitigation Strategy (2021) (3)
Factors Associated with HIV Seroprevalence among Participants Enrolling at a Needle Exchange Program (2002) (3)
Provision of water and sanitation services. (2010) (3)
Pandemic preparedness and hard to reach populations. (2007) (2)
Street-outreach Improves Detection but not Referral for Drug Users with Latent Tuberculosis, New York City (2011) (2)
The infection control practitioner as investigator of clinical phenomena. (1987) (2)
Lack of association between estimated World Trade Center plume intensity and respiratory symptoms among New York City residents outside of Lower Manhattan. (2009) (2)
Immunity against hepatitis C virus infection [2] (multiple letters) (2002) (2)
Physical Urban Environment (2011) (2)
HIV INFECTION AND AIDS AMONG U.S. PRISON INMATES (1992) (2)
Erratum: Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 ositive women (AIDS (2008) 22:11 (1355-1363)) (2008) (2)
Erratum: Does bleach disinfection of syringes protect against Hepatitis C infection among young adult injection drug users? (Epidemiology (2002) 13 (738-741)) (2004) (2)
Nutritional status and its behavioral and clinical correlates in the hers cohort of HIV-infected and at-risk uninfected women (1997) (2)
Differences among U.S. States in Estimating the Number of People Living with HIV/AIDS: Impact on Allocation of Federal Ryan White Funding (2007) (2)
Why Cities and Health? (2019) (2)
Urban Health Systems: Overview (2008) (2)
824-P: Ecological Momentary Assessment of Diabetes Self-Management: A Systematic Review of Methods and Procedures (2019) (2)
Correlates of attitudes concerning human immunodeficiency (1994) (2)
Urban Health (2019) (2)
Using nominal group technique to identify barriers and facilitators to preventing HIV using combination same-day pre-exposure prophylaxis and medications for opioid use disorder (2022) (2)
Markers of response to zidovudine monotherapy among treated HIV seroconverters. Italian Seroconversion Study. (1997) (2)
Chapter 2Urban Health in the Context of Twenty‐First‐Century Megatrends (2011) (2)
Identifying injection drug users at risk of overdose (2007) (2)
Social Network Structures in African American Churches: Implications for Health Promotion Programs (2018) (2)
Durable HIV Suppression Among People Who Inject Drugs From a Community-Based Cohort Study in Baltimore, Maryland, 1997 – 2017 (2020) (2)
#44 Changing racial/ethnic disparities in homicide mortality in nyc 1990–98 (2002) (1)
The bottom line on cash incentives with drug users. (2009) (1)
Consistent Effects of TSG 101 Genetic Variability on Multiple Outcomes of Exposure to Human Immunodeficiency Virus Type 1 † (2018) (1)
EVIDENCE OF BLOOD‐BORNE TRANSMISSION OF HUMAN HERPESVIRUS 8 (HHV‐8) AMONG WOMEN WITH HIV RISK BEHAVIORS.: ABSTRACT 4 (2000) (1)
Racial Disparities in Incidence of and Survival from Out-of-Hospital Cardiac Arrest (2007) (1)
Persistenceof viraemia and importance of follow-up in acute hepatitis C virusinfection (1999) (1)
Sterile Needles: Human Immunodeficiency Virus in Diabetic Intravenous Drug Users-Reply (1992) (1)
This issue of the Journal of urban health (2001) (1)
Debate on the paper by David Vlahov (2006) (1)
Healthy urban governance (2010) (1)
Evaluation of an Intervention to Increase Screening Colonscopy in an Urban Public Hospital Setting (2006) (1)
INFERENCE FOR SURVIVAL CURVES WITH INFORMATIVELY COARSENED DISCRETE EVENT-TIME DATA: APPLICATION TO ALIVE (2007) (1)
Measuring PrEP Preferences Among U.S. Military Men Who Have Sex with Men: Results of an Adaptive Choice Based Conjoint Analysis Study (2020) (1)
Description and Review of Research Projects in Three Cities (1995) (1)
Pandemic Housing Policy: Examining the Relationship Among Eviction, Housing Instability, Health Inequity, and COVID-19 Transmission (2020) (1)
Post-traumatic stress symptoms in the general population after a disaster. Implications for public health: Evidence from a study of the NYC metropolitan area in the aftermath of September 11 (2006) (1)
Nurse Practitioner–Led Integrated Rapid Access to HIV Prevention for People Who Inject Drugs (iRaPID): Protocol for a Pilot Randomized Controlled Trial (2022) (1)
A community-based Needle Clean-Up Project. (1994) (1)
Abstract 11105: Real Time Racial Microaggression and Physiological Stress Responses Among Young and Middle Aged Black Adults (2021) (1)
Feasibility, acceptability, tolerability of targeted naltrexone for non-dependent methamphetamine – Using and binge-drinking men who have sex with men (2017) (1)
Changing Living Conditions; Changing Health (2006) (1)
The Epidemiology of Injection Drug Use (1995) (1)
RE: A Drug Feared in the 70's Is Tied to Suspect in Killings (2003) (1)
Urban Health Issues (2007) (1)
Advances in Brief Reduced Risk of AIDS Lymphoma in Individuals Heterozygous for the CCR 5D 32 Mutation 1 (1999) (1)
Expanding a Comprehensive Strategy for Overdose Prevention in the USA (2019) (1)
Genome-wide association study reveals genetic variants associated with HIV-1C infection in a Botswana study population (2021) (1)
496: Urban Neighborhood Socioeconomic Status and Incidence of Depression in a Population-Based Cohort Study (2005) (1)
A Systematic Review of Risk Factors for Suicide Among Persons Living with HIV (1996–2020) (2022) (1)
Occupational Risk of Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Infections Among Funeral Service Practitioners in Maryland (1995) (1)
Systematic Surveys in Informal Settlements: Challenges in Moving Toward Health Equity (2019) (1)
Psychological Disorders Following the World Trade Center Attacks (2002) (0)
Integrating HIV Prevention Activities into the HIV Medical Care Setting: A Report from the NYC HIV Centers Consortium (2006) (0)
Centers for Disease Control and Prevention: Epidemic Intelligence Service's 50th Anniversary (2001) (0)
When to start therapy. Authors' reply (2005) (0)
Incidence and risk factors for HIV-1 infection—a summary of what is known and the psychiatric relevance (1996) (0)
Directions for Future Research (2019) (0)
On the Role of Genetic Testing for Personalized Drug Overdose Management (2013) (0)
Partnership with Palo Alto VA Gives MEPN Students Critical Experience (2015) (0)
Urban Health : Latin America and the Caribbean (2007) (0)
Enumeration of hard-to-reach populations for a community-based vaccine distribution study (2005) (0)
Do Age-Friendly Community Initiatives Form a Biopolitical Paradigm? (2020) (0)
Training health care workers to meet the new OSHA HBV/HIV proposed standard (1989) (0)
Knowledge of therapeutics for human immunodeficiency virus infection among intravenous drug users. (1992) (0)
Posttraumatic Stress Disorder in Manhattan , New York City , After the September 11 th Terrorist (2002) (0)
Policing, Drugs, and Declining Homicide Levels in New York City in the 1990's (2006) (0)
Immunity against hepatitis C virus infection (2002) (0)
Sensitivity Analysis for Informatively Interval-Censored Discrete Time-to-Event Data (2004) (0)
Reports Self-reported Antiretroviral Therapy in Injection Drug Users (2000) (0)
Suicide among older adults in long-term care: 1990-2005 (2008) (0)
[The difference between men and women drug users in seroconversion risk factors]. (2001) (0)
556-S: Factors Associated with the use of ‘Street Methadone’ by HIV-Seropositive Injection Drug users in Four Us Cities (2005) (0)
Clinical Effects of Synthetic Cannabinoid Receptor Agonists Compared with Marijuana in Emergency Department Patients with Acute Drug Overdose (2016) (0)
Commentary on: Meta-analysis and public policy: opportunity for nursing impact. (2012) (0)
Dimensions of the Problem (1995) (0)
RevisitingtheRoleoftheUrbanEnvironmentinSubstance Use:TheCaseofAnalgesicOverdoseFatalities (2013) (0)
This issue of the Journal of Urban Health (2006) (0)
Liver, Pancreas and Biliary Tract Liver enzyme values in injection drug users with chronic hepatitis C (2005) (0)
Examining the impact of socio-ecological variables on race-specific homicide rates in New York City (2010) (0)
Accuracy of patient recall for date of peripheral intravenous catheter insertion. (1987) (0)
Prevalence and correlates of illicit methadone use in a large urban area: a cross-sectional study (2008) (0)
Utility of Cardiac Troponin to Predict Drug Overdose Mortality (2015) (0)
Professional Association Positions on Needle Exchange and Bleach Distribution Programs (1995) (0)
This issue of the Journal of Urban Health (2006) (0)
The Effectiveness of Bleach as a Disinfectant of Injection Drug Equipment (1995) (0)
NeighborhoodCharacteristicsandChangein DepressiveSymptomsAmongOlderResidents ofNewYorkCity (2009) (0)
Low power? Use two-dimensional confidence regions as a graphical method for depicting uncertainty. (1994) (0)
The Design and Selected Early Findings of the HIV Epidemiology Research (HER) Study: A Prospective Cohort Study of HIV Infection in U.S. Women: (1997) (0)
Preferences for Long-Acting and Alternative Modalities for PrEP among Military Men Who Have Sex with Men: Segmentation Results of an Adaptive Choice-Based Conjoint Analysis Study (2022) (0)
Vaccine disparities can be overcome (2005) (0)
Racial Discrimination, Sedentary Time, and Physical Activity in African Americans: Quantitative Study Combining Ecological Momentary Assessment and Accelerometers (Preprint) (2020) (0)
A quantitative assessment of the frequency and magnitude of heterogeneous treatment effects in studies of the health effects of social policies (2023) (0)
Evaluation of Possible Effects of Continued Drug Use on HIV Progression among Women (2004) (0)
T-Lymphocyte Subsets in Intravenous Drug Users With HIV-1 Infection-Reply (1992) (0)
Erratum: Integrating HIV prevention activities into the HIV medical care setting: A report from the NYC HIV centers consortium (Journal of Urban Health DOI: 10.1007/s11524-005-9004-7) (2007) (0)
Chapter 3 Urbanicity , Urbanization , and the Urban Environment (2007) (0)
HIV INFECTION AND ASSOCIATED IMMUNOSUPPRESSION ACCELERATES PROGRESSION OF HPV RELATED CERVICAL NEOPLASIA IN INJECTION DRUG USING WOMEN: 11 (1997) (0)
Negotiating the Gerontological Uncanny and Passing Tactics for Aging in Place (2020) (0)
Associations Between COVID-19 Vaccine Hesitancy and Socio-Spatial Factors in NYC Transit Workers 50 Years and Older (2022) (0)
Pandemic preparedness and hard to reach populations. (2007) (0)
Immunity against hepatitis C virus infection. Authors' reply (2002) (0)
Erratum: Validity of self-reported needle exchange attendance among injection drug users: Implications for program evaluation (American Journal of Epidemiology (2002) 155 (169-175)) (2002) (0)
The impact of M. tuberculosis infection on subsequent disseminated MAC disease in KV-infected persons (1997) (0)
Championing Nursing That Respects Patients’ Cultural and Religious Beliefs (2015) (0)
The CHANGE Study: Methods and Sample Description for a Cross-Sectional Study of Heroin Cessation in New York City (2015) (0)
Comprar Handbook of Urban Health · Populations, Methods, and Practice | Galea, Sandro | 9780387857701 | Springer (2009) (0)
SPECIAL SESSION: Evidence to Weigh for Harm Reduction to Reduce HIV and Other Infections in Persons Who Inject Drugs (2019) (0)
Risk of HIV-1 transmission in the workplace (1991) (0)
Creating Healthier Cities (2006) (0)
New Partnerships Train Nurses to Work in a Patient-Centered Primary Care Environment (2015) (0)
HIV disease symptoms in intravenous drug users and homosexual men compared (1993) (0)
The Long-Term Outcome of a Personal Network-Oriented HIV Prevention Intervention for Injection Drug Users : The SAFE Study 1 (0)
Reply to Phillips and Lampe (2005) (0)
Prospective study of hepatitis C viral load after community-acquired infection (1997) (0)
Contribution Neighborhood Poverty and Injection Cessation in a Sample of Injection Drug Users (2010) (0)
Evolving the Urban Health Agenda (2005) (0)
Body mass index and obesity-related behaviors in African American church-based networks: A social network analysis (2023) (0)
Strategies for improving immunization rates among hard-to-reach populations (2007) (0)
STERILE NEEDLES : HUMAN IMMUNODEFICIENCY VIRUS IN DIABETIC INTRAVENOUS DRUG ESTERS. AUTHOR'S REPLIES (1992) (0)
Au th or ' s pe rs on al co py Defining Neighborhood Boundaries for Urban Health Research (2007) (0)
The Impact of Needle Exchange and Bleach Distribution Programs (1995) (0)
Appendix. HER Study Investigators (2010) (0)
Change in attitudes and knowledge of problem drug use and harm reduction among a community cohort in Kabul, Afghanistan. (2016) (0)
Prevention of Human Immunodeficiency Virus in Street-Recruited Injection Drug Users (2000) (0)
Is HTLV-II a risk factor for low CD4 levels in HIV-infected intravenous drug users ? (1993) (0)
Commentary: Targeting HIV interventions to the most at risk—hindsight is 20/20 (2005) (0)
Measuring PrEP Preferences Among At-Risk Military Populations: Results of an Adaptive Choice Based Conjoint Analysis Study (2020) (0)
COVID-19 Vaccine Hesitancy Among Medicare Beneficiaries with and Without Cancer History: A US Population-based Study (2022) (0)
The Legal Environment (1995) (0)
InvestigatingtheEffectofSocialChangeson Age-SpecificGun-RelatedHomicideRatesin NewYorkCityDuringthe1990s (2010) (0)
UC San Francisco School of Nursing and Tenderloin Safe Passage (2015) (0)
AIDS: overview, immunology, virology, and informational needs. (1989) (0)
201: Racial Differences in Incidence of and Survival from Out-of-Hospital Cardiac Arrest in New York City (2005) (0)
Corrigendum to “Epidemiology of Subway-Related Fatalities in New York City, 1990-2003” [Journal of Safety Research 39 (2008) 583-588] (2009) (0)
Ethical and Logistical Challenges of Conducting Research Involving World Trade Center Survivors (2002) (0)
EXPANDING SYRINGE ACCESS (2000) (0)
Considering Bias in the Assessment of Respiratory Symptoms among Residents of Lower Manhattan following the Events of September 11, 2001 (2005) (0)
Needle Exchange and Bleach Distribution Programs in the United States (1995) (0)
This issue of theJournal of Urban Health (2001) (0)
Drug use and the urban environment (2005) (0)
On the Role of Genetic Testing for Personalized Drug Overdose Management (2013) (0)
Abstracts of the Second Annual International Conference on Urban Health. October 15-18, 2003. New York, New York, USA. (2003) (0)
Erratum: Evaluation of an intervention to increase screening colonscopy in an urban public hospital setting (Journal of Urban Health (242) DOI: 10.1007/s11524-006-9029-6) (2007) (0)

This paper list is powered by the following services:

Other Resources About David Vlahov

en.wikipedia.org

What Schools Are Affiliated With David Vlahov?

David Vlahov is affiliated with the following schools:

David Vlahov's Academic­Influence.com Rankings

David Vlahov's Degrees

Why Is David Vlahov Influential?

David Vlahov's Published Works

Published Works

Other Resources About David Vlahov

What Schools Are Affiliated With David Vlahov?

David Vlahov's AcademicInfluence.com Rankings